Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of intravesical KD01 in high-risk non-muscle-invasive bladder cancer
CTR20261748Phase 2Active
- Sponsor
- KDGene
- Start
- Jun 2026
- Modality
- Oncolytic Viruses → Oncolytic Therapeutics, Gene Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of KD01 in non-muscle-invasive bladder cancer (NMIBC), sponsored by KDGene. Started Jun 2026; status: active.
02
Drugs
KD01
03
Conditions
non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on CTR20261748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261748.